Concepedia

Michael Kitt

MK

Statistics

Publications

2

Citations

150

H-Index

2

Active since

2013

Affiliations

Portola Pharmaceuticals (United States)(Current)

McMaster University

Michael Kitt is an author at Portola Pharmaceuticals (United States) specializing in clinical trials, vascular biology, and clinical pharmacology.

Top concepts

Publications per year

2013–2013

2

Publications

2

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet Alfa (PRT064445), An Antidote For Fxa Inhibitors

Mark Crowther, M. Manasar.Vandana, Michael Kitt et al. · Blood · 2013 · 115 citations

Abstract 10: Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Pharmacokinetic and Pharmacodynamic Study of PRT064445, a Universal Antidote for Factor Xa Inhibitors

Mark Crowther, Michael Kitt, Matthew W. McClure et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2013 · 35 citations

, , +20

1–2 of 2